HEADER APOPTOSIS 03-JUN-19 6P6C TITLE CS-ROSETTA MODEL OF PEA-15 DEATH EFFECTOR DOMAIN IN THE COMPLEX WITH TITLE 2 ERK2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ASTROCYTIC PHOSPHOPROTEIN PEA-15; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: 15 KDA PHOSPHOPROTEIN ENRICHED IN ASTROCYTES,PHOSPHOPROTEIN COMPND 5 ENRICHED IN DIABETES,PED; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PEA15; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS PROTEIN-PROTEIN INTERACTION, MAP KINASE, APOPTOSIS EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR Y.WEI,S.CRESPO FLORES,A.CABEZAS,S.HASSAN REVDAT 4 15-MAY-24 6P6C 1 REMARK REVDAT 3 14-JUN-23 6P6C 1 REMARK REVDAT 2 11-DEC-19 6P6C 1 REMARK REVDAT 1 24-JUL-19 6P6C 0 JRNL AUTH S.L.CRESPO-FLORES,A.CABEZAS,S.HASSAN,Y.WEI JRNL TITL PEA-15 C-TERMINAL TAIL ALLOSTERICALLY MODULATES JRNL TITL 2 DEATH-EFFECTOR DOMAIN CONFORMATION AND FACILITATES JRNL TITL 3 PROTEIN-PROTEIN INTERACTIONS. JRNL REF INT J MOL SCI V. 20 2019 JRNL REFN ESSN 1422-0067 JRNL PMID 31284641 JRNL DOI 10.3390/IJMS20133335 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CS-ROSETTA REMARK 3 AUTHORS : SHEN, VERNON, BAKER AND BAX REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6P6C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-JUN-19. REMARK 100 THE DEPOSITION ID IS D_1000241975. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 150 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 10 MM SODIUM PHOSPHATE, 150 MM REMARK 210 SODIUM CHLORIDE, 0.1 MM DTT, 50 REMARK 210 UM SODIUM AZIDE, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D CBCA(CO)NH; REMARK 210 3D HNCACB REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, NMRVIEW, CS-ROSETTA REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 3000 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-10 REMARK 465 RES C SSSEQI REMARK 465 GLU A 91 REMARK 465 GLU A 92 REMARK 465 ASP A 93 REMARK 465 GLU A 94 REMARK 465 LEU A 95 REMARK 465 ASP A 96 REMARK 465 THR A 97 REMARK 465 LYS A 98 REMARK 465 LEU A 99 REMARK 465 THR A 100 REMARK 465 ARG A 101 REMARK 465 ILE A 102 REMARK 465 PRO A 103 REMARK 465 SER A 104 REMARK 465 ALA A 105 REMARK 465 LYS A 106 REMARK 465 LYS A 107 REMARK 465 TYR A 108 REMARK 465 LYS A 109 REMARK 465 ASP A 110 REMARK 465 ILE A 111 REMARK 465 ILE A 112 REMARK 465 ARG A 113 REMARK 465 GLN A 114 REMARK 465 PRO A 115 REMARK 465 SER A 116 REMARK 465 GLU A 117 REMARK 465 GLU A 118 REMARK 465 GLU A 119 REMARK 465 ILE A 120 REMARK 465 ILE A 121 REMARK 465 LYS A 122 REMARK 465 LEU A 123 REMARK 465 ALA A 124 REMARK 465 PRO A 125 REMARK 465 PRO A 126 REMARK 465 PRO A 127 REMARK 465 LYS A 128 REMARK 465 LYS A 129 REMARK 465 ALA A 130 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 2 ILE A 39 109.84 -59.98 REMARK 500 3 ALA A 44 -71.09 -61.27 REMARK 500 8 ARG A 71 72.46 62.48 REMARK 500 10 LEU A 55 94.69 -68.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30614 RELATED DB: BMRB REMARK 900 CS-ROSETTA MODEL OF PEA-15 DEATH EFFECTOR DOMAIN IN THE COMPLEX REMARK 900 WITH ERK2 DBREF 6P6C A 1 130 UNP Q15121 PEA15_HUMAN 1 130 SEQRES 1 A 130 MET ALA GLU TYR GLY THR LEU LEU GLN ASP LEU THR ASN SEQRES 2 A 130 ASN ILE THR LEU GLU ASP LEU GLU GLN LEU LYS SER ALA SEQRES 3 A 130 CYS LYS GLU ASP ILE PRO SER GLU LYS SER GLU GLU ILE SEQRES 4 A 130 THR THR GLY SER ALA TRP PHE SER PHE LEU GLU SER HIS SEQRES 5 A 130 ASN LYS LEU ASP LYS ASP ASN LEU SER TYR ILE GLU HIS SEQRES 6 A 130 ILE PHE GLU ILE SER ARG ARG PRO ASP LEU LEU THR MET SEQRES 7 A 130 VAL VAL ASP TYR ARG THR ARG VAL LEU LYS ILE SER GLU SEQRES 8 A 130 GLU ASP GLU LEU ASP THR LYS LEU THR ARG ILE PRO SER SEQRES 9 A 130 ALA LYS LYS TYR LYS ASP ILE ILE ARG GLN PRO SER GLU SEQRES 10 A 130 GLU GLU ILE ILE LYS LEU ALA PRO PRO PRO LYS LYS ALA HELIX 1 AA1 MET A 1 ASN A 13 1 13 HELIX 2 AA2 THR A 16 GLU A 29 1 14 HELIX 3 AA3 PRO A 32 GLU A 37 1 6 HELIX 4 AA4 THR A 41 HIS A 52 1 12 HELIX 5 AA5 ASP A 56 SER A 70 1 15 HELIX 6 AA6 ARG A 72 SER A 90 1 19 CISPEP 1 LYS A 57 ASP A 58 7 6.16 CISPEP 2 LYS A 57 ASP A 58 10 5.80 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1